GGTI-2418
| CAS No. | 501010-06-6 | Cat. No. | BCP30523 |
| Name | GGTI-2418 | ||
| Synonyms | GGTI2418; GGTI 2418; PTX-100; PTX 100; PTX100;Geranylgeranyl transferase inhibitor-2148; | ||
| Formula | C23H31N5O4 | M. Wt | 441.53 |
| Description | GGTI-2418 is a synthetic peptidomimetic inhibitor of geranylgeranyltransferase I (GGTase I) that appears to induce apoptosis by downregulating several pivotal oncogenic and tumor survival pathways. GGTase I catalyzes the lipid posttranslational modification which is required for the function of Rho GTPases (frequently found aberrantly activated in human cancer). GGTase I inhibitors block Rho function in cancer cells and induce a G1 phase cell cycle arrest by a mechanism involving induction of the CDK inhibitors p21waf and p27kip, CDK2 and CDK4 inhibition and hypophoshorylation of the tumor suppressor Rb. GGTase I inhibitors also induce apoptosis by a mechanism involving downregulation of the expression of survivin and suppression of the activation of PI3K/Akt. | ||
| Pathways | GPCR/G Protein | ||
| Targets | Ras/Rho | ||
Structure
Part data of this page collected from the open network resources, so Biochempartner can not guarantee its accuracy.
For product details of different batches, please contact our Customer
- Service & Tech Support:orders@biochempartner.com
- Website:www.biochempartner.com
Products are for research use only and not for human use. We do not sell to patients.